DBV Technologies | 8-K: Current report
DBV Technologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: Current report
DBV Technologies | F-6 POS: Post-effective amendment to a F-6EF registration
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies | DEF 14A: Definitive information statements
DBV Technologies | PRE 14A: Preliminary proxy statements relating to merger or acquisition
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: Current report
DBV Technologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K/A: Current report (Amendment)
DBV Technologies | 8-K/A: Current report (Amendment)
DBV Technologies | 8-K: DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
DBV Technologies | 8-K: Current report
DBV Technologies | 8-K: DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
No Data
No Data